MS relapse reduction: low-cost vitamin D or high cost new drug

Wednesday March 21, 2012

BG-12 (dimethyl fumarate) drug submitted to FDA March 2012

BG-12 provides about 50% reduction of MS relapses. Raising vitamin D by 20 ng provides about 50% reduction in MS relapses BG-12 is patented, so the company can charge a lot of money and make huge profits $3 billion annual revenue anticipated Bloomberg Nov 2011

Guess at the annual costs for similar 50% reduction in MS relapses

~hs~~hs~~hs~~hs~~hs~~hs~~hs~$10 Vitamin D: many POSITIVE side effects $10,000 BG-12: possible NEGATIVE side effects

See VitaminDWiki


Permalink: https://vitamindwiki.com/blogpost76-MS-relapse-reduction-low-cost-vitamin-D-or-high-cost-new-drug